Trials / Completed
CompletedNCT01971450
Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
Prospective Multicentre Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 89 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Local, prospective, multicenter, non-comparative, non-interventional, observational study. It is planed to assess compliance of patients with PH (pulmonary hypertension) with the physician's recommendation in real practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iloprost (Ventavis, BAYQ6256) |
Timeline
- Start date
- 2013-11-21
- Primary completion
- 2017-06-28
- Completion
- 2018-04-18
- First posted
- 2013-10-29
- Last updated
- 2019-03-26
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT01971450. Inclusion in this directory is not an endorsement.